This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| International Society for Addiction Medicine | |
|---|---|
| Name | International Society for Addiction Medicine |
| Abbreviation | ISAM |
| Formation | 20th century |
| Type | Professional association |
| Headquarters | Geneva |
| Region served | Global |
| Leader title | President |
International Society for Addiction Medicine is a professional association connecting clinicians, researchers, policymakers, and educators in the fields of substance use and behavioral addictions. The society fosters collaboration among specialists associated with institutions such as World Health Organization, United Nations Office on Drugs and Crime, European Monitoring Centre for Drugs and Drug Addiction, Pan American Health Organization, and Centers for Disease Control and Prevention to address clinical practice, public health, and policy. It works alongside academies and professional bodies like American Psychiatric Association, Royal College of Psychiatrists, College of Physicians and Surgeons, International Association for Suicide Prevention, and International Narcotics Control Board to promote standards of care, research translation, and workforce development.
The society emerged from gatherings of clinicians influenced by conferences such as the International Congress on Alcoholism, meetings convened by the World Federation for Mental Health, symposia linked to Addiction Research Centers and congresses connected with the Royal Society of Medicine, American Society of Addiction Medicine, International Society of Addiction Psychiatry and Psychology, and regional forums in Geneva, Vienna, New York City, London, and Tokyo. Early leaders included figures associated with institutions like National Institute on Drug Abuse, Institute of Psychiatry, Karolinska Institutet, University of California, San Francisco, and McGill University, and the society’s evolution paralleled initiatives such as the Declaration of Helsinki discussions, the Global Burden of Disease studies, and WHO guideline processes. Over time the society collaborated with organizations implicated in harm reduction debates—Harm Reduction International, Médecins Sans Frontières, and European Centre for Disease Prevention and Control—and contributed to consensus statements during events like the United Nations General Assembly Special Session on Drugs.
The society’s mission aligns with goals championed by World Health Organization, United Nations, World Psychiatric Association, International Council of Nurses, and World Medical Association to improve prevention, treatment, and recovery services, emphasizing evidence from studies at Johns Hopkins University, Harvard Medical School, Oxford University, Cambridge University, and Imperial College London. Objectives include promoting clinical standards resonant with guidelines from National Institute for Health and Care Excellence, American Society of Addiction Medicine, Canadian Centre on Substance Use and Addiction, and European Monitoring Centre for Drugs and Drug Addiction, advancing research priorities reflected in reports from National Institutes of Health, Wellcome Trust, Bill & Melinda Gates Foundation, and fostering training programs modeled after curricula at University of Sydney, University of Toronto, Monash University, and King's College London.
Governance follows models used by entities such as International Committee of the Red Cross, Royal Society, American Medical Association, and British Medical Association, with an elected executive board, committees resembling those in European Respiratory Society and International Neuropsychological Society, and a secretariat located in proximity to agencies like World Health Organization and United Nations Office at Geneva. Leadership roles mirror titles found in International Olympic Committee and World Bank structures, with working groups for ethics similar to panels in Committee on Publication Ethics and scientific committees modeled after International Council for Science practices. Financial oversight and bylaws draw on templates used by Bill & Melinda Gates Foundation, Rockefeller Foundation, and university endowment boards at Yale University and Princeton University.
The society organizes international congresses akin to events hosted by World Congress of Psychiatry, European Congress of Clinical Microbiology & Infectious Diseases, International AIDS Conference, and regional meetings paralleling Asia Pacific Addiction Conference, African Union health summits, and Pan American Health Organization workshops. Educational offerings include workshops developed with partners such as Society for Neuroscience, International Association of Universities, European Federation of Neurological Societies, and training modules comparable to programs at Addiction Technology Transfer Center Network and SAMHSA. Satellite symposia often feature speakers affiliated with University College London, Columbia University}}, Stanford University, McMaster University, and invited panels from Global Fund, UNICEF, and World Bank.
The society issues position statements and collaborates on guidelines with bodies such as World Health Organization, National Institute for Health and Care Excellence, American Psychiatric Association, European Monitoring Centre for Drugs and Drug Addiction, and publishes proceedings and reviews in journals alongside The Lancet, JAMA, Addiction (journal), British Medical Journal, and Journal of Substance Abuse Treatment. It contributes to clinical practice recommendations reflecting evidence from trials registered at ClinicalTrials.gov and meta-analyses cited in databases like PubMed, Cochrane Collaboration, and reports by Institute of Medicine. Consensus documents frequently reference frameworks used by WHO Model List of Essential Medicines, UNODC-WHO International Standards, and policy briefs from OECD.
Membership comprises clinicians, researchers, and trainees associated with institutions including National Institutes of Health, European Commission, Asian Development Bank, African Development Bank, and universities such as University of Melbourne, Seoul National University, Peking University, and University of São Paulo. Regional chapters align with entities like European Union, Association of Southeast Asian Nations, African Union, Organization of American States, and national societies such as American Society of Addiction Medicine, Indian Psychiatric Society, Japanese Society of Addiction Medicine, and Brazilian Society of Psychiatry. Membership benefits reflect services provided by professional organizations such as Royal College of Physicians, Canadian Medical Association, and include fellowship pathways analogous to those at Royal College of Psychiatrists.
The society partners with international agencies and advocacy groups including World Health Organization, United Nations Office on Drugs and Crime, Global Fund to Fight AIDS, Tuberculosis and Malaria, Médecins Sans Frontières, Harm Reduction International, and foundations such as Wellcome Trust and Open Society Foundations to influence policies debated at forums like the United Nations Commission on Narcotic Drugs, World Health Assembly, G7 Summit, and G20 Summit. Its advocacy efforts coordinate with campaigns led by American Heart Association, International Federation of Red Cross and Red Crescent Societies, and International Labour Organization to promote integrated care, destigmatization initiatives, and research funding priorities recognized by funders such as National Science Foundation and European Research Council.
Category:Addiction organizations Category:International medical associations